Page last updated: 2024-11-08

aspartic acid and Diabetes Mellitus, Type 2

aspartic acid has been researched along with Diabetes Mellitus, Type 2 in 51 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"Glycogen levels were also lower in this region."5.36Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis. ( Benie, AJ; Bouman, SD; Schousboe, A; Sickmann, HM; Waagepetersen, HS, 2010)
"Older adults with type 2 diabetes mellitus have an increased risk of fracture despite a paradoxically higher average bone mineral density."1.91Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case-control study. ( Bain, J; Colón-Emeric, C; Ilkayeva, O; Lee, RH; Muehlbauer, M; Pieper, C; Wixted, D, 2023)
"The hypercalcemia was specifically induced by calcium L-aspartate and eldecalcitol."1.91A Case of Milk-Alkali Syndrome Caused by Diuretic-Induced Alkalosis and Polypharmacy. ( Goda, K; Kenzaka, T; Mizutani, N, 2023)
"Children of mothers with gestational diabetes mellitus (GDM) are more prone to acquire type 2 diabetes and obesity as adults."1.91Oral probiotics increased the proportion of Treg, Tfr, and Breg cells to inhibit the inflammatory response and impede gestational diabetes mellitus. ( Feng, Y; Jie, Q; Liang, W; Qin, J; Wu, W; Yang, D; Zhi, X, 2023)
"The number of patients with diabetic neuropathic pain (DNP) continues to increase, but available treatments are limited."1.72Reactive Oxygen Species Contributes to Type 2 Diabetic Neuropathic Pain via the Thioredoxin-Interacting Protein-NOD-Like Receptor Protein 3- N -Methyl-D-Aspartic Acid Receptor 2B Pathway. ( Cao, H; Li, J; Li, X; Luo, GH; Wang, JW; Wei, N; Wu, SS; Ye, XY; Zhang, ZH, 2022)
"Eighty six patients with Type 2 diabetes mellitus (T2DM) were enrolled for this study."1.43[Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus]. ( Niu, H; Shen, J; Shi, X; Wang, R; Wang, S; Wu, J; Yang, H; Zhang, Y; Zhou, S, 2016)
"The metabolic alterations of type 2 diabetes are associated with protection against IR injury at onset but detrimental effects in late diabetes mellitus consistent with progressive dysfunction of glucose oxidation."1.39Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation. ( Birkler, RI; Bøtker, HE; Dalgas, C; Johannsen, M; Løfgren, B; Povlsen, JA; Støttrup, NB, 2013)
"The pathogenesis of type 2 diabetes is characterized by impaired insulin action and increased hepatic glucose production (HGP)."1.39In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model. ( Han, W; Lee, P; Leong, W; Lim, M; Radda, GK; Tan, T, 2013)
"In the type 2 diabetes model GABA levels were increased suggesting that brain glycogen serves a role in maintaining a proper ratio between excitatory and inhibitory neurotransmitters in type 2 diabetes."1.38Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat model. ( Benie, AJ; Bouman, SD; Schousboe, A; Sickmann, HM; Waagepetersen, HS, 2012)
"Glycogen levels were also lower in this region."1.36Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis. ( Benie, AJ; Bouman, SD; Schousboe, A; Sickmann, HM; Waagepetersen, HS, 2010)
"Patients with type 2 diabetes and major depression (n=20) were scanned along with patients with diabetes alone (n=24) and healthy controls (n=21) on a 1."1.34Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. ( Ajilore, O; Binesh, N; Darwin, C; Haroon, E; Kumar, A; Kumaran, S; Miller, J; Mintz, J; Thomas, MA, 2007)
"A total of 83% of participants had type 2 diabetes."1.33T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. ( Beck, SR; Bowden, DW; Burdon, KP; Freedman, BI; Langefeld, CD; Liu, Y; Rich, SS; Wagenknecht, LE, 2005)
"To clarify the genetic background of IDDMS, we analyzed HLA-DRB1, -DQB1 and -DQA1 alleles, phenotypes, and genotypes and compared them with acute-onset type 1 diabetes, non-insulin-dependent diabetes mellitus (NIDDM), and control subjects."1.33Slowly progressing form of type 1 diabetes mellitus in children: genetic analysis compared with other forms of diabetes mellitus in Japanese children. ( Kazahari, M; Kikuchi, N; Koike, A; Matsuura, N; Nomoto, K; Ohtsu, S; Takubo, N; Yokota, F, 2005)
"Myo-inositol was even more elevated in patients with polyneuropathy (p = 0."1.32Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. ( Feuerbach, S; Fründ, R; Geissler, A; Schölmerich, J; Zietz, B, 2003)
"D76N was not associated with type 2 diabetes, either in our population or when all reported studies in Caucasians were combined."1.32Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes? ( Elbein, SC; Karim, MA, 2004)
"However, NIDDM patients with the Tyr allele, which was previously reported to be associated with insulin resistance, tended to have lower BMIs than those without this allele (Asp/Asp: 24."1.30Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM. ( Babaya, N; Fujisawa, T; Hamada, Y; Ikegami, H; Kawabata, Y; Kawaguchi, Y; Nojima, K; Ogihara, T; Shen, GQ; Shintani, M; Ueda, H; Yamada, K, 1998)

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19902 (3.92)18.7374
1990's5 (9.80)18.2507
2000's16 (31.37)29.6817
2010's20 (39.22)24.3611
2020's8 (15.69)2.80

Authors

AuthorsStudies
Zhang, J1
Xian, TZ1
Wu, MX1
Li, C1
Wang, W1
Man, F1
Zhang, X1
Wang, X2
Pan, Q1
Guo, L1
Wang, JW1
Ye, XY1
Wei, N1
Wu, SS1
Zhang, ZH1
Luo, GH1
Li, X1
Li, J1
Cao, H1
Lv, Y3
Zheng, Y3
Zhao, X3
Li, Z3
Wang, G3
Lee, RH1
Bain, J1
Muehlbauer, M1
Ilkayeva, O1
Pieper, C1
Wixted, D1
Colón-Emeric, C1
Mizutani, N1
Goda, K1
Kenzaka, T1
Liang, W1
Feng, Y1
Yang, D1
Qin, J1
Zhi, X1
Wu, W1
Jie, Q1
Fukuda, M1
Nagao, Y1
Li, S1
Yin, C1
Zhao, W1
Lian, X1
Hong, Q1
Luo, HH1
Feng, XF1
Yang, XL1
Hou, RQ1
Fang, ZZ1
Wu, GY1
Zhang, Q2
Wu, JL1
Jing, L1
Tan, Y1
Qiu, TC1
Zhao, J1
Wang, S2
Wang, J1
Zhang, R1
Zhao, A1
Zheng, X1
Yan, D1
Jiang, F1
Jia, W2
Hu, C1
Vangipurapu, J1
Stancáková, A1
Smith, U1
Kuusisto, J1
Laakso, M1
Fried, PJ1
Pascual-Leone, A1
Bolo, NR1
Lin, Y1
Zhou, J1
Sha, L1
Li, Y1
Qu, X1
Liu, L1
Chen, H1
An, Z1
Wang, Y2
Sun, C1
Povlsen, JA1
Løfgren, B1
Dalgas, C1
Birkler, RI1
Johannsen, M1
Støttrup, NB1
Bøtker, HE1
Zhang, M2
Sun, X2
Zhang, Z2
Meng, Q2
Chen, J1
Ma, X1
Geng, H2
Sun, L2
Hajek, T1
Calkin, C1
Blagdon, R1
Slaney, C1
Alda, M1
Sinha, S1
Ekka, M1
Sharma, U1
P, R1
Pandey, RM1
Jagannathan, NR1
Tong, J1
Zhu, X1
Qian, R1
Liang, Q1
Yin, YW1
Wang, Q1
Sun, QQ1
Hu, AM1
Liu, HL1
Stamenkovic, JA1
Andersson, LE1
Adriaenssens, AE1
Bagge, A1
Sharoyko, VV1
Gribble, F1
Reimann, F1
Wollheim, CB1
Mulder, H1
Spégel, P1
Kieffer, DM1
Harteveld, CL1
Lee, DH1
Schiemsky, T1
Desmet, KJ1
Gillard, P1
Shi, X1
Zhang, Y1
Niu, H1
Wang, R1
Shen, J1
Zhou, S1
Yang, H1
Wu, J1
Achilles, EI1
Maus, V1
Fink, GR1
Maintz, D1
van Eimeren, T1
Mpotsaris, A1
Heikkilä, O1
Lundbom, N1
Timonen, M1
Groop, PH1
Heikkinen, S1
Mäkimattila, S1
Odeberg, J1
Larsson, CA1
Råstam, L1
Lindblad, U1
Ouederni, TB1
Sanchez-Corona, J1
Flores Martinez, SE1
Ben Maiz, H1
Skhiri, HA1
Abid, HK1
Benammar-Elgaaied, A1
Tiehuis, A1
van der Meer, F1
Mali, W1
Pleizier, M1
Biessels, GJ1
Kappelle, J1
Luijten, P1
Sickmann, HM2
Waagepetersen, HS2
Schousboe, A2
Benie, AJ2
Bouman, SD2
Lee, P1
Leong, W1
Tan, T1
Lim, M1
Han, W1
Radda, GK1
D'Alfonso, R1
Marini, MA1
Frittitta, L1
Sorge, R1
Frontoni, S1
Porzio, O1
Mariani, LM1
Lauro, D1
Gambardella, S1
Trischitta, V1
Federici, M1
Lauro, R1
Sesti, G1
Stefan, N1
Kovacs, P1
Stumvoll, M1
Hanson, RL1
Lehn-Stefan, A1
Permana, PA1
Baier, LJ1
Tataranni, PA1
Silver, K1
Bogardus, C1
Geissler, A1
Fründ, R1
Schölmerich, J1
Feuerbach, S1
Zietz, B1
Rudofsky, G1
Reismann, P1
Witte, S1
Humpert, PM1
Isermann, B1
Chavakis, T1
Tafel, J1
Nosikov, VV1
Hamann, A1
Nawroth, P1
Bierhaus, A1
Chen, MW1
Yang, MG1
Wang, CJ1
Wang, YM1
Xu, XP1
Liu, SQ1
Sun, HY1
Elbein, SC1
Karim, MA1
Liu, Y1
Burdon, KP1
Langefeld, CD1
Beck, SR1
Wagenknecht, LE1
Rich, SS1
Bowden, DW1
Freedman, BI1
Ohtsu, S1
Takubo, N1
Kazahari, M1
Nomoto, K1
Yokota, F1
Kikuchi, N1
Koike, A1
Matsuura, N1
Ajilore, O1
Haroon, E1
Kumaran, S1
Darwin, C1
Binesh, N1
Mintz, J1
Miller, J1
Thomas, MA1
Kumar, A1
Schäffler, A1
Zeitoun, M1
Wobser, H1
Buechler, C1
Aslanidis, C1
Herfarth, H1
Modi, S1
Bhattacharya, M1
Sekhri, T1
Rana, P1
Tripathi, RP1
Khushu, S1
Shen, GQ1
Ikegami, H1
Kawaguchi, Y1
Fujisawa, T1
Hamada, Y1
Ueda, H1
Shintani, M1
Nojima, K1
Kawabata, Y1
Yamada, K1
Babaya, N1
Ogihara, T1
Dubois-Laforgue, D2
Caillat-Zucman, S2
Djilali-Saiah, I1
Larger, E1
Mercadier, A1
Boitard, C2
Bach, JF1
Timsit, J2
Bissé, E1
Zorn, N1
Eigel, A1
Lizama, M1
Huaman-Guillen, P1
März, W1
Van Dorsselaer, A1
Wieland, H1
Cai, H1
Colagiuri, S1
Wilcken, DE1
Maegawa, H1
Shi, K1
Hidaka, H1
Iwai, N1
Nishio, Y1
Egawa, K1
Kojima, H1
Haneda, M1
Yasuda, H1
Nakamura, Y1
Kinoshita, M1
Kikkawa, R1
Kashiwagi, A1
Song, DK1
Ahn, YH1
Bae, JH1
Park, WK1
Hong, YS1
Ho, WK1
Earm, YE1
Filer, LJ1
Stegink, LD1
Deaver, OE1
Wander, RC1
McCusker, RH1
Berdanier, CD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway (HP FFF)[NCT03480594]30 participants (Anticipated)Observational2018-10-01Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for aspartic acid and Diabetes Mellitus, Type 2

ArticleYear
Changes in cerebral metabolites in type 2 diabetes mellitus: A meta-analysis of proton magnetic resonance spectroscopy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2017, Volume: 45

    Topics: Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Diabetes Mellitus, Type 2; Humans; In

2017
Toll-like receptor 4 gene Asp299Gly and Thr399Ile polymorphisms in type 2 diabetes mellitus: a meta-analysis of 15,059 subjects.
    Diabetes research and clinical practice, 2015, Volume: 107, Issue:3

    Topics: Amino Acid Substitution; Aspartic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Genetic Pre

2015

Trials

1 trial available for aspartic acid and Diabetes Mellitus, Type 2

ArticleYear
Comparing the effects of twice-daily exenatide and insulin on renal function in patients with type 2 diabetes mellitus: secondary analysis of a randomized controlled trial.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022, Volume: 70, Issue:7

    Topics: Aspartic Acid; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide-1 Receptor; Glycated Hemo

2022

Other Studies

48 other studies available for aspartic acid and Diabetes Mellitus, Type 2

ArticleYear
Reactive Oxygen Species Contributes to Type 2 Diabetic Neuropathic Pain via the Thioredoxin-Interacting Protein-NOD-Like Receptor Protein 3- N -Methyl-D-Aspartic Acid Receptor 2B Pathway.
    Anesthesia and analgesia, 2022, 10-01, Volume: 135, Issue:4

    Topics: Animals; Aspartic Acid; Caspases; Cell Cycle Proteins; Diabetes Mellitus, Experimental; Diabetes Mel

2022
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
The relationship between islet β-cell function and metabolomics in overweight patients with Type 2 diabetes.
    Bioscience reports, 2023, 02-27, Volume: 43, Issue:2

    Topics: Adult; Aspartic Acid; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Cysteine; Diabetes Me

2023
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case-control study.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2023, Volume: 34, Issue:7

    Topics: Aged; Amino Acids; Asparagine; Aspartic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Fatty

2023
A Case of Milk-Alkali Syndrome Caused by Diuretic-Induced Alkalosis and Polypharmacy.
    Medicina (Kaunas, Lithuania), 2023, Jul-22, Volume: 59, Issue:7

    Topics: Aged; Aged, 80 and over; Alkalosis; Aspartic Acid; Calcium; Diabetes Mellitus, Type 2; Diuretics; Fe

2023
Oral probiotics increased the proportion of Treg, Tfr, and Breg cells to inhibit the inflammatory response and impede gestational diabetes mellitus.
    Molecular medicine (Cambridge, Mass.), 2023, 09-08, Volume: 29, Issue:1

    Topics: Animals; Asparagine; Aspartic Acid; B-Lymphocytes, Regulatory; Diabetes Mellitus, Type 2; Diabetes,

2023
Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report.
    Journal of medical case reports, 2019, Oct-21, Volume: 13, Issue:1

    Topics: Arginine; Aspartic Acid; Biomarkers; Deafness; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Growth

2019
Application of Hydrogen Proton Magnetic Resonance Technology Combined with Brain Neurometabolite Analysis in the Treatment of Cognitive Impairment Caused by Type 2 Diabetes Mellitus.
    World neurosurgery, 2020, Volume: 138

    Topics: Adult; Aged; Aspartic Acid; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Female; Humans; Hydrog

2020
Interactive effects of asparagine and aspartate homeostasis with sex and age for the risk of type 2 diabetes risk.
    Biology of sex differences, 2020, 10-22, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Aging; Asian People; Asparagine; Aspartic Acid; China; Diabetes Mellitus, Type 2;

2020
Association between serum haptoglobin and carotid arterial functions: usefulness of a targeted metabolomics approach.
    Cardiovascular diabetology, 2019, 01-11, Volume: 18, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cas

2019
Nine Amino Acids Are Associated With Decreased Insulin Secretion and Elevated Glucose Levels in a 7.4-Year Follow-up Study of 5,181 Finnish Men.
    Diabetes, 2019, Volume: 68, Issue:6

    Topics: Aged; Alanine; Amino Acids; Aspartic Acid; Blood Glucose; Diabetes Mellitus, Type 2; Finland; Follow

2019
Diabetes and the link between neuroplasticity and glutamate in the aging human motor cortex.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2019, Volume: 130, Issue:9

    Topics: Aged; Aged, 80 and over; Aging; Aspartic Acid; Creatine; Diabetes Mellitus, Type 2; Female; Glucose;

2019
Metabolite differences in the lenticular nucleus in type 2 diabetes mellitus shown by proton MR spectroscopy.
    AJNR. American journal of neuroradiology, 2013, Volume: 34, Issue:9

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Biomarkers; Choline; Corpus Striatum; Creatine; Diabetes Mel

2013
Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Animals; Aspartic Acid; Blood Glucose; Diabetes Mellitus, Type 2; Glucose; Heart Function Tests; Hem

2013
Brain metabolite changes in patients with type 2 diabetes and cerebral infarction using proton magnetic resonance spectroscopy.
    The International journal of neuroscience, 2014, Volume: 124, Issue:1

    Topics: Aged; Aspartic Acid; Blood Glucose; Brain; Cerebral Infarction; Choline; Creatine; Diabetes Mellitus

2014
Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders.
    Biological psychiatry, 2015, Feb-01, Volume: 77, Issue:3

    Topics: Adult; Aspartic Acid; Bipolar Disorder; Brain; Creatine; Cross-Sectional Studies; Diabetes Mellitus,

2015
Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy.
    BMC research notes, 2014, Jan-17, Volume: 7

    Topics: Aspartic Acid; Brain Chemistry; Choline; Creatinine; Diabetes Mellitus, Type 2; Glucose; Glutamic Ac

2014
Brain metabolite alterations demonstrated by proton magnetic resonance spectroscopy in diabetic patients with retinopathy.
    Magnetic resonance imaging, 2014, Volume: 32, Issue:8

    Topics: Adult; Aspartic Acid; Brain; Case-Control Studies; Choline; Corpus Striatum; Diabetes Mellitus, Type

2014
Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
    The Biochemical journal, 2015, May-15, Volume: 468, Issue:1

    Topics: Animals; Aspartic Acid; Cell Line; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Gl

2015
Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC.
    Clinical chemistry and laboratory medicine, 2016, Volume: 54, Issue:5

    Topics: Adult; Aspartic Acid; Cations; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; D

2016
[Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2016, Volume: 41, Issue:2

    Topics: Adult; Aspartic Acid; Case-Control Studies; Cerebrum; Choline; Cognition; Cognition Disorders; Creat

2016
[Hemichorea with Contralateral High Signal Intensity Putaminal Lesion on T1-Weighted Images in Non-Ketotic Hyperglycemia].
    Fortschritte der Neurologie-Psychiatrie, 2016, Volume: 84, Issue:4

    Topics: Aspartic Acid; Choline; Chorea; Creatine; Diabetes Complications; Diabetes Mellitus, Type 2; Diffusi

2016
Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism.
    Metabolic brain disease, 2008, Volume: 23, Issue:3

    Topics: Adult; Anthropometry; Aspartic Acid; Blood Glucose; Choline; Creatine; Diabetes Mellitus, Type 2; Hu

2008
The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus.
    BMC cardiovascular disorders, 2008, Dec-10, Volume: 8

    Topics: Alleles; Aspartic Acid; Data Collection; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Age

2008
The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population.
    Clinical biochemistry, 2009, Volume: 42, Issue:10-11

    Topics: Aspartic Acid; Black People; Diabetes Mellitus, Type 2; Ethnicity; Female; Genetic Predisposition to

2009
MR spectroscopy of cerebral white matter in type 2 diabetes; no association with clinical variables and cognitive performance.
    Neuroradiology, 2010, Volume: 52, Issue:2

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognition; Cognition Disorders; Creatine; Di

2010
Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010, Volume: 30, Issue:8

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Blood Glucose; Brain; Diabetes Mellitus, Type 2; gamma

2010
Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat model.
    Neurochemistry international, 2012, Volume: 60, Issue:3

    Topics: Animals; Aspartic Acid; Brain Chemistry; Cerebral Cortex; Diabetes Mellitus, Type 2; gamma-Aminobuty

2012
In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model.
    Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:2

    Topics: Animals; Aspartic Acid; Carbon Isotopes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2;

2013
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:1

    Topics: Adult; Aged; Alleles; Aspartic Acid; Cohort Studies; Diabetes Mellitus, Type 2; Fibroblasts; Gene Fr

2003
Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.
    Diabetes, 2003, Volume: 52, Issue:6

    Topics: Adult; Amino Acid Substitution; Animals; Arizona; Aspartic Acid; Base Sequence; Body Composition; Co

2003
Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2003, Volume: 111, Issue:7

    Topics: Adult; Aspartic Acid; Blood Glucose; Brain; Chlorides; Choline; Creatinine; Diabetes Mellitus, Type

2003
Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes.
    Diabetes care, 2004, Volume: 27, Issue:1

    Topics: Amino Acid Substitution; Aspartic Acid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabet

2004
[Study on the association of PPP1R3 gene polymorphism with type 2 diabetes in Han population of Anhui province].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2004, Volume: 25, Issue:6

    Topics: Adult; Alleles; Aspartic Acid; China; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genotype; H

2004
Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes?
    Diabetes care, 2004, Volume: 27, Issue:8

    Topics: Age of Onset; Amino Acid Substitution; Asparagine; Aspartic Acid; Case-Control Studies; Diabetes Mel

2004
T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study.
    Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:4

    Topics: Aged; Albuminuria; Aspartic Acid; Creatinine; Cysteine; Diabetes Mellitus, Type 1; Diabetes Mellitus

2005
Slowly progressing form of type 1 diabetes mellitus in children: genetic analysis compared with other forms of diabetes mellitus in Japanese children.
    Pediatric diabetes, 2005, Volume: 6, Issue:4

    Topics: Age of Onset; Arginine; Asian People; Aspartic Acid; Autoantibodies; Case-Control Studies; Child; Ch

2005
Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Chemistry; Choline; Creatine; Depressive Disord

2007
Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases.
    Cardiovascular diabetology, 2007, Feb-13, Volume: 6

    Topics: Amino Acid Substitution; Aspartic Acid; Chronic Disease; Cohort Studies; Cytokines; Diabetes Mellitu

2007
Assessment of the metabolic profile in Type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy.
    Magnetic resonance imaging, 2008, Volume: 26, Issue:3

    Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Diabetes Mellitus, Type 2; Female; Humans; Hypothyro

2008
Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM.
    Diabetes care, 1998, Volume: 21, Issue:7

    Topics: Adult; Aged; Alleles; Amino Acid Substitution; Aspartic Acid; Body Mass Index; Data Interpretation,

1998
Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM.
    Diabetes care, 1998, Volume: 21, Issue:8

    Topics: Amino Acid Substitution; Aspartic Acid; Cysteine; Diabetes Mellitus, Type 2; Hemochromatosis; Hemoch

1998
Hemoglobin Rambam (beta69[E13]Gly-->Asp), a pitfall in the assessment of diabetic control: characterization by electrospray mass spectrometry and HPLC.
    Clinical chemistry, 1998, Volume: 44, Issue:10

    Topics: Amino Acid Sequence; Aspartic Acid; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2;

1998
A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
    Diabetes care, 1998, Volume: 21, Issue:12

    Topics: Albuminuria; Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cerebrovascular Disorders; Dia

1998
The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
    Diabetes, 1999, Volume: 48, Issue:7

    Topics: 3' Untranslated Regions; Alleles; Aspartic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Fe

1999
Evidence of enhancement of malate-aspartate shuttle activity in beta cells of streptozotocin-induced non-insulin-dependent diabetic rats.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:1

    Topics: Adenosine Triphosphate; Animals; Aspartic Acid; Blood Glucose; Cells, Cultured; Diabetes Mellitus, E

2000
Clinical characteristics of type 2 diabetes in patients with mutations of HFE.
    Diabetes & metabolism, 2000, Volume: 26, Issue:1

    Topics: Amino Acid Substitution; Aspartic Acid; Cysteine; Diabetes Mellitus, Type 2; Female; Ferritins; Hemo

2000
Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.
    Diabetes care, 1989, Volume: 12, Issue:1

    Topics: Adult; Aspartame; Aspartic Acid; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Erythrocytes;

1989
Diet effects on membrane phospholipid fatty acids and mitochondrial function in BHE rats.
    The Journal of nutrition, 1986, Volume: 116, Issue:7

    Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Animals; Aspartic Acid; Coconut Oil; Corn Oil; Dia

1986